276 related articles for article (PubMed ID: 12297534)
1. Angiogenesis in the corpus luteum of early pregnancy in the marmoset and the effects of vascular endothelial growth factor immunoneutralization on establishment of pregnancy.
Rowe AJ; Morris KD; Bicknell R; Fraser HM
Biol Reprod; 2002 Oct; 67(4):1180-8. PubMed ID: 12297534
[TBL] [Abstract][Full Text] [Related]
2. Mid-luteal angiogenesis and function in the primate is dependent on vascular endothelial growth factor.
Dickson SE; Bicknell R; Fraser HM
J Endocrinol; 2001 Mar; 168(3):409-16. PubMed ID: 11241172
[TBL] [Abstract][Full Text] [Related]
3. Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40).
Wulff C; Wilson H; Rudge JS; Wiegand SJ; Lunn SF; Fraser HM
J Clin Endocrinol Metab; 2001 Jul; 86(7):3377-86. PubMed ID: 11443214
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis and vascular endothelial growth factor expression in the equine corpus luteum.
Al-zi'abi MO; Watson ED; Fraser HM
Reproduction; 2003 Feb; 125(2):259-70. PubMed ID: 12578540
[TBL] [Abstract][Full Text] [Related]
5. Regulation and role of vascular endothelial growth factor in the corpus luteum during mid-pregnancy in rats.
Kashida S; Sugino N; Takiguchi S; Karube A; Takayama H; Yamagata Y; Nakamura Y; Kato H
Biol Reprod; 2001 Jan; 64(1):317-23. PubMed ID: 11133689
[TBL] [Abstract][Full Text] [Related]
6. Expression of vascular endothelial growth factor and its receptors in the porcine corpus luteum during the estrous cycle and early pregnancy.
Kaczmarek MM; Kowalczyk AE; Waclawik A; Schams D; Ziecik AJ
Mol Reprod Dev; 2007 Jun; 74(6):730-9. PubMed ID: 17120307
[TBL] [Abstract][Full Text] [Related]
7. Cyclic changes in expression of mRNA of vascular endothelial growth factor, its receptors Flt-1 and KDR/Flk-1, and Ets-1 in human corpora lutea.
Endo T; Kitajima Y; Nishikawa A; Manase K; Shibuya M; Kudo R
Fertil Steril; 2001 Oct; 76(4):762-8. PubMed ID: 11591411
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy.
Sugino N; Kashida S; Takiguchi S; Karube A; Kato H
J Clin Endocrinol Metab; 2000 Oct; 85(10):3919-24. PubMed ID: 11061557
[TBL] [Abstract][Full Text] [Related]
9. Localization of mRNA for vascular endothelial growth factor (VEGF), angiopoietins and their receptors during the peri-implantation period and early pregnancy in marmosets (Callithrix jacchus).
Rowe AJ; Wulff C; Fraser HM
Reproduction; 2003 Aug; 126(2):227-38. PubMed ID: 12887279
[TBL] [Abstract][Full Text] [Related]
10. Preovulatory treatment of mice with anti-VEGF receptor 2 antibody inhibits angiogenesis in corpora lutea.
Zimmermann RC; Hartman T; Bohlen P; Sauer MV; Kitajewski J
Microvasc Res; 2001 Jul; 62(1):15-25. PubMed ID: 11421657
[TBL] [Abstract][Full Text] [Related]
11. Changes of messenger RNAs encoding vascular endothelial growth factor and its receptors during the development and maintenance of caprine corpora lutea.
Kawate N; Tsuji M; Tamada H; Inaba T; Sawada T
Mol Reprod Dev; 2003 Feb; 64(2):166-71. PubMed ID: 12506348
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis in the human corpus luteum: simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization.
Wulff C; Dickson SE; Duncan WC; Fraser HM
Hum Reprod; 2001 Dec; 16(12):2515-24. PubMed ID: 11726568
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor (VEGF) receptors in rat corpus luteum: regulation by oestradiol during mid-pregnancy.
Sugino N; Kashida S; Takiguchi S; Karube-Harada A; Kato H
Reproduction; 2001 Dec; 122(6):875-81. PubMed ID: 11732982
[TBL] [Abstract][Full Text] [Related]
14. Expression and tissue concentration of vascular endothelial growth factor, its receptors, and localization in the bovine corpus luteum during estrous cycle and pregnancy.
Berisha B; Schams D; Kosmann M; Amselgruber W; Einspanier R
Biol Reprod; 2000 Oct; 63(4):1106-14. PubMed ID: 10993833
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis in the human corpus luteum: localization and changes in angiopoietins, tie-2, and vascular endothelial growth factor messenger ribonucleic acid.
Wulff C; Wilson H; Largue P; Duncan WC; Armstrong DG; Fraser HM
J Clin Endocrinol Metab; 2000 Nov; 85(11):4302-9. PubMed ID: 11095472
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary.
Ravindranath N; Little-Ihrig L; Phillips HS; Ferrara N; Zeleznik AJ
Endocrinology; 1992 Jul; 131(1):254-60. PubMed ID: 1612003
[TBL] [Abstract][Full Text] [Related]
17. Administration of vascular endothelial growth factor Trap during the 'post-angiogenic' period of the luteal phase causes rapid functional luteolysis and selective endothelial cell death in the marmoset.
Fraser HM; Wilson H; Wulff C; Rudge JS; Wiegand SJ
Reproduction; 2006 Oct; 132(4):589-600. PubMed ID: 17008470
[TBL] [Abstract][Full Text] [Related]
18. Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor.
Fraser HM; Dickson SE; Lunn SF; Wulff C; Morris KD; Carroll VA; Bicknell R
Endocrinology; 2000 Mar; 141(3):995-1000. PubMed ID: 10698175
[TBL] [Abstract][Full Text] [Related]
19. The vascular endothelial growth factor/fms-like tyrosine kinase system in human ovary during the menstrual cycle and early pregnancy.
Otani N; Minami S; Yamoto M; Shikone T; Otani H; Nishiyama R; Otani T; Nakano R
J Clin Endocrinol Metab; 1999 Oct; 84(10):3845-51. PubMed ID: 10523040
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis during follicular development in the primate and its inhibition by treatment with truncated Flt-1-Fc (vascular endothelial growth factor Trap(A40)).
Wulff C; Wiegand SJ; Saunders PT; Scobie GA; Fraser HM
Endocrinology; 2001 Jul; 142(7):3244-54. PubMed ID: 11416048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
